Research In Brief
This article was originally published in The Tan Sheet
Executive Summary
Cranberry & diabetes: Cranberry supplementation "may have value for diabetics," although further research is warranted, according to a randomized, double-blind study presented at the Federation of American Societies for Experimental Biology meeting in New Orleans April 20-24. Belinda Chambers, University of Maine, et al., found insulin and glucose levels were significantly lower at week 12 in adults under 50 supplemented with cranberry than in placebo group at week six. Researchers suggest "more research on dosage and in patients with worse glycemic control is needed." Study recruited 27 adults with type-2 diabetes; fasting blood analyses were conducted at baseline, six, 12 weeks. Subjects took six .5 g capsules daily containing spray-dried cranberry juice (equal to a glass of cranberry juice cocktail) or placebo...
You may also be interested in...
Psyllium seed husk/heart disease health claim for food approved.
PSYLLIUM SEED HUSK/HEART DISEASE CLAIM FOR FOOD APPROVED by FDA in a final rule published in the Federal Register Feb. 18 and effective immediately. The agency is amending current food labeling regulations to allow foods containing soluble fiber from psyllium seed husk, when included as part of a diet low in saturated fat and cholesterol, to bear labeling claiming a link to a reduction of the risk of coronary heart disease (CHD). Soluble fiber from psyllium seed husk has been shown in studies to lower blood total and LDL ("bad") cholesterol.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands